As of January 2025, InnoPharmax has a market cap of $49.83M. This makes InnoPharmax the world's 23350th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $49.83M | -0.58% |
2023 | $50.12M | 48.71% |
2022 | $33.70M | -32.75% |
2021 | $50.12M | 0.29% |
2020 | $49.97M | 40.98% |
2019 | $35.44M | 66.21% |
2018 | $21.32M | -59.58% |
2017 | $52.76M | -39.92% |
2016 | $87.81M | -48.23% |
2015 | $169.63M | 23.82% |
2014 | $137.00M | -0.94% |
2013 | $138.30M | 18.56% |
2012 | $116.65M | - |